Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
A clinical trial evaluating the use of the Corus CAD (ASGES) diagnostic test in primary care decision making has been withdrawn.
-
EMA withdrawal · 2018-12-20EMA Withdrawn: Ivabradine JensonR (ivabradine hydrochloride) — JensonR+ Limited
The EMA has withdrawn Ivabradine JensonR (ivabradine hydrochloride) from the market under the MAH JensonR+ Limited, effective as of 11/11/20…
-
CLINICAL_TRIALS withdrawal · 2014-07-02Clinical Trial Update: A Multi-centric Study to Assess the Efficacy of Sigmart in Subjects With Recurrent Angina After Coronary Revascularization [Phase 4]
A Phase 4 multicenter trial evaluating Sigmart for recurrent angina after coronary revascularization has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-09Clinical Trial Update: Hybrid Intraprocedural Imaging Based on 2 Different Imaging Methods [NA]
A clinical trial evaluating hybrid intraprocedural imaging methods for angina pectoris and left ventricular wall motion abnormalities has be…
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial evaluating the effects of ranolazine on exercise duration in patients with chronic stable angina and coronary artery disease w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
A clinical trial comparing left ventricular volume and wall stress using dobutamine versus exercise echocardiography has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2006-09-08Clinical Trial Update: Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina [Phase 4]
A Phase 4 trial comparing rosiglitazone versus gliclazide in adults with type 2 diabetes and angina has been withdrawn.